Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Paclitaxel in Angiosarcoma (ANGIOTAX)
NCT00217607Phase 2Completed
- Sponsor
- Unicancer
- Start
- Feb 2005
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in angiosarcoma, Lymphangiosarcoma (STS), sponsored by Unicancer. Started Feb 2005; status: completed.
02
Drugs
paclitaxel
03
Conditions
angiosarcomaLymphangiosarcoma (STS)
Beyond the preview
Go deeper on NCT00217607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217607.